Board Meeting5 Nov 2026, 06:20 pm
Concord Drugs Board Meeting on Nov 12 to Approve Q2 FY27 Results
AI Summary
Concord Drugs Ltd has announced that its Board of Directors will convene on November 12, 2026, to approve the un-audited financial results for the quarter ending September 30, 2026. The meeting will also address other necessary business items. In line with the company's insider trading policy, the trading window for designated persons will remain closed until 48 hours after the results are declared.
Key Highlights
- Board meeting scheduled for November 12, 2026.
- To approve financial results for the quarter ending Sep 30, 2026.
- Trading window closed for designated persons.
- Results will be un-audited (Standalone & Consolidated).
Price Impact
More from CONCORD